NCT04694326

Brief Summary

Our purpose is to determine the prevalence of undiagnosed diabetes by checking HbA1c in patients hospitalized outside internal medicine services and assess whether or not there is a difference between those without diabetes awareness and those with known diabetes in terms of age, sex, education status, presence of comorbidity and Body Mass Index (BMI).

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
630

participants targeted

Target at P75+ for all trials

Timeline
Completed

Started Apr 2017

Shorter than P25 for all trials

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

April 20, 2017

Completed
9 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

December 31, 2017

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

December 31, 2017

Completed
3 years until next milestone

First Submitted

Initial submission to the registry

January 1, 2021

Completed
4 days until next milestone

First Posted

Study publicly available on registry

January 5, 2021

Completed
Last Updated

March 5, 2021

Status Verified

January 1, 2021

Enrollment Period

9 months

First QC Date

January 1, 2021

Last Update Submit

March 4, 2021

Conditions

Keywords

Diabetes MellitusDiabetes UnawarenessİnpatientHbA1c

Outcome Measures

Primary Outcomes (1)

  • Diabetes Unawaraness Prevalance

    Diabetes unawaraness prevalance in inpatient settings

    14 days

Study Arms (1)

Inpatients

Patients who were inpatients of units other than internal medicine services and internal medicine side-branch services

Diagnostic Test: HbA1c

Interventions

HbA1cDIAGNOSTIC_TEST

The participants' age, sex, education level, known diseases, unit of hospitalization and inpatient diagnosis were questioned and recorded. Height, weight and waist circumference measurements were taken. Fasting blood sugar and HbA1c measurements were made

Also known as: Anthropometric measures, Glucose
Inpatients

Eligibility Criteria

Age18 Years+
Sexall
Age GroupsAdult (18-64), Older Adult (65+)
Sampling MethodNon-Probability Sample
Study Population

The study was conducted at two different tertiary healthcare institutions located in Istanbul in Turkey. Patientswho were inpatients of units other than internal medicine services and internal medicine side-branch services at or over the age of 18 whose anthropometric measurements could be made were included. . The internal units included neurology, dermatology, physiotherapy and rehabilitation, cardiology, infectious diseases and pulmonology services, while the surgical units included general surgery, cardiovascular surgery, pulmonary surgery, orthopedics and traumatology, brain surgery, ophthalmology, urology, gynecology and plastic surgery services.

You may qualify if:

  • Inpatients of units other than internal medicine services and internal medicine side-branch services at or
  • Over the age of 18
  • Anthropometric measurements could be made were included

You may not qualify if:

  • Had comorbidities that could affect their anthropometric measurements (heart failure, edema, liver cirrhosis, cancer, cachexia, Cushing syndrome, etc.),
  • Who had been using steroids for more than a month,
  • Pregnant
  • Postoperative period

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Sultan Abdülhamid Han Training and Research Hospital

Istanbul, 34660, Turkey (Türkiye)

Location

MeSH Terms

Conditions

Diabetes Mellitus

Condition Hierarchy (Ancestors)

Glucose Metabolism DisordersMetabolic DiseasesNutritional and Metabolic DiseasesEndocrine System Diseases

Study Design

Study Type
observational
Observational Model
COHORT
Time Perspective
CROSS SECTIONAL
Target Duration
14 Days
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

January 1, 2021

First Posted

January 5, 2021

Study Start

April 20, 2017

Primary Completion

December 31, 2017

Study Completion

December 31, 2017

Last Updated

March 5, 2021

Record last verified: 2021-01

Data Sharing

IPD Sharing
Will not share

Locations